Lucintel Forecasts the Global Macromolecular CDMO Market to is expected to grow with a CAGR of 7.8% from 2025 to 2031
Lucintel Forecasts the Global Macromolecular CDMO Market to is expected to grow with a CAGR of 7.8% from 2025 to 2031
Blog Article
According to a market report by Lucintel, the future of the global macromolecular CDMO market looks promising with opportunities in the pharmaceutical company and biotechnology company markets. The global macromolecular CDMO market is expected to grow with a CAGR of 7.8% from 2025 to 2031. The major drivers for this market are growing outsourcing trend in pharmaceutical industry, rising need for specialized production capabilities, and rising regulatory support for biologic drug approvals.
A more than 150-page report to understand trends, opportunity and forecast in macromolecular CDMO market to 2031 by type (API development and API manufacturing), application (pharmaceutical company and biotechnology company), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, API manufacturing is expected to witness higher growth over the forecast period due togrowing demand for large-scale production.
Within the application category, pharmaceutical company is expected to witness higher growth due to their established infrastructure and broader scope of drug development.
Download sample by clicking on macromolecular CDMO market
In terms of region, North America is expected to witness the highest growth over the forecast period due to its established biopharmaceutical industry and supportive regulatory environment.
WuXi Biologics, GenScript Biotech Corporation, Zhenge Biotech, Samsung Biologics, Catalent, Cambrex Corp., AGC Biologics, Recipharm AB, Siegfried Holding, LabCorp Drug Development are the major suppliers in the macromolecular CDMO market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Duct Air Quality Sensors Market
AC Drive Market
Compressor Market
Portable Gaming Console Market
Dual Chamber Prefilled Syringe Market